BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20861182)

  • 1. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
    Huang QM; Tomida S; Masuda Y; Arima C; Cao K; Kasahara TA; Osada H; Yatabe Y; Akashi T; Kamiya K; Takahashi T; Suzuki M
    Cancer Res; 2010 Nov; 70(21):8407-16. PubMed ID: 20861182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
    Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
    Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression and mutation-inducing activity of AID in human lung cancer.
    Shinmura K; Igarashi H; Goto M; Tao H; Yamada H; Matsuura S; Tajima M; Matsuda T; Yamane A; Funai K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
    Ann Surg Oncol; 2011 Jul; 18(7):2084-92. PubMed ID: 21290192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH; Liu NH; Wang J; Bai H; Mao L
    Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
    Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
    Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B
    Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.
    Gray SG; Al-Sarraf N; Baird AM; Gately K; McGovern E; O'Byrne KJ
    Clin Lung Cancer; 2008 Nov; 9(6):367-74. PubMed ID: 19073520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glutathione S-transferase M2 in stage I/II non-small cell lung cancer and alleviation of DNA damage exposure to benzo[a]pyrene.
    Tang SC; Sheu GT; Wong RH; Huang CY; Weng MW; Lee LW; Hsu CP; Ko JL
    Toxicol Lett; 2010 Feb; 192(3):316-23. PubMed ID: 19900515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer.
    O-Wang J; Kawamura K; Tada Y; Ohmori H; Kimura H; Sakiyama S; Tagawa M
    Cancer Res; 2001 Jul; 61(14):5366-9. PubMed ID: 11454676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
    Miko E; Margitai Z; Czimmerer Z; Várkonyi I; Dezso B; Lányi A; Bacsó Z; Scholtz B
    FEBS Lett; 2011 Apr; 585(8):1191-6. PubMed ID: 21439283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.